FluoroPharma, Inc.

Related Content

This is a BFPET PET nuclear cardiac imaging scan for myocardial perfusion, nuclear cardiology
Feature | Nuclear Imaging| Dave Fornell
PET vs. SPECT - Will PET Dominate Over the Next Decade?

Just when positron emission tomography (PET) appears to be eclipsing single photon emission computed tomography (SPECT) ...

Home July 23, 2013
arrow
CardioPET
Feature | Thijs Spoor
Why PET Will Beat SPECT in the Next Decade

The next generation of positron emission tomography (PET) imaging agents will herald an age when PET will eclipse single ...

Home May 14, 2013
arrow
News
Initial Images Show Positive Myocardiac Perfusion Results for BFPET

August 3, 2012 — FluoroPharma Medical Inc., a company specializing in the development of novel diagnostic imaging ...

Home August 03, 2012
arrow
News
FluoroPharma Presents Phase I Study Results of New PET Myocardial Perfusion Tracer

June 15, 2009 - FluoroPharma Inc. will present phase I data relating to the safety, dosimetry, and pharmacokinetics in ...

Home June 15, 2009
arrow
News
FluoroPharma Nets Patent for Imaging Cardiovascular Plaque using FDG

January 28, 2009 - FluoroPharma Inc., a molecular imaging company engaged in the discovery and development of ...

Home January 27, 2009
arrow
News
Positive Safety Results Reported for New Myocardial Perfusion Tracer for PET

July 24, 2008 - FluoroPharma said it achieved positive phase I test results for BFPET, a novel Fluorine-18 labeled ...

Home July 23, 2008
arrow
News
Novel PET Tracer Enters Trials

Clinical trials to study the efficacy of a novel cardiac viability imaging agent is now underway. FluoroPharma, Inc., an ...

Home October 04, 2006
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now